神经调节设备市场分析及预测(按规模、份额、增长、趋势划分)2030 年

  • Report Code : TIPRE00018069
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

[研究报告] 2022年神经调节设备市场价值为57.3亿美元,预计到2030年将达到116.1亿美元。预计2022年至2030年该市场的复合年增长率为9.2%。

市场洞察和分析师观点:

该报告包括增长前景以及当前神经调节设备市场趋势及其在预测期内的可预见影响。

神经调节的使用正在快速增长,广泛应用一系列基于植入式和非侵入性技术的方法,用于治疗神经精神和神经系统疾病。颅内皮质刺激 (ICS)、经颅磁刺激 (TMS)、深部脑刺激 (DBS) 和经颅直流电刺激 (tDCS) 等疗法在一系列神经精神和神经系统疾病中显示出有希望的结果。神经调节装置是可以调节神经系统活动的先进医疗仪器。该技术用于治疗肌张力障碍、帕金森病、震颤等运动障碍;耳鸣;强迫症;感觉障碍;癫痫;膀胱控制;头痛;慢性疼痛;中风;最低意识状态;痉挛;和脊髓损伤。脊髓损伤病例的增加和神经系统疾病患病率的增加等因素导致神经调节设备市场规模不断增长。

市场驱动因素:

老年人群容易患神经系统疾病。影响老年人的常见神经系统疾病有神经病、帕金森病、阿尔茨海默病、肌张力障碍等。据联合国经济和社会事务部统计,2022年,全球65岁及以上人口为7.71亿。预计到 2030 年,老年人口将达到 9.94 亿,到 2050 年将达到 16 亿。在美国和加拿大等国家,与老年人口增长相关的运动障碍和精神疾病患病率很高。根据帕金森基金会的数据,帕金森症状在平均 60 岁的人群中很常见。

加拿大心理学协会指出,强迫症 (OCD) 影响着加拿大约 2% 的人口。世界卫生组织 (WHO) 指出,癫痫是一种引起癫痫发作的神经系统疾病,影响全世界约 5000 万人。根据美国神经病学学会的数据,中风是美国第三大死因,其次是阿尔茨海默病,是第六大死因。来自同一来源的统计数据显示,近100万美国人受到帕金森病的影响,每年至少报告6万例新病例。神经系统疾病的患病率不断上升,加上抑郁症和慢性疼痛等与生活方式相关的疾病,导致越来越多地采用先进技术的产品。

因此,容易患神经系统疾病的老年人口不断增加,这些疾病的患病率不断增加以及对神经系统疾病巨大负担的认识不断增强,推动了神经调节设备市场的增长。

神经科学专注于治疗中风、头痛、多发性硬化症和其他严重病例等疾病。近年来,即使在发达国家,熟练的神经病学劳动力也相对短缺。在美国,有超过 5,700 家医院;然而,这些医院的神经外科医生不足3700人。造成神经外科劳动力不足的一个突出因素是无法在适当的时间内培养出经过充分培训的神经外科医生。城市地区拥有技术先进的神经内科设施。然而,由于缺乏专业人士,农村地区提供的治疗有限。因此,熟练的神经外科医生的短缺阻碍了神经调节设备市场的增长。



报告细分和范围:

“神经调节设备市场分析”已经进行通过考虑细分市场——类型、应用、生物材料和最终用户。

细分分析:

神经调节设备市场按类型分为外部和内部。 2022 年,内部神经调节领域在神经调节设备市场中占有较大份额。然而,外部神经调节领域在 2022 年至 2030 年期间可能会出现更高的复合年增长率。术语“内部神经调节”描述了使用医疗设备为特定神经元目标提供电、化学或其他形式的刺激,以调节或改变神经系统的活动。该技术用于治疗神经血管疾病、运动异常、癫痫、慢性疼痛以及粪便和尿液失禁。

神经调节设备市场,按类型 - 2022 年和 2030 年

按最终用户划分,神经调节设备市场分为医院、诊所和家庭医疗保健。 2022年,医院领域主导了神经调节设备市场份额。由于众多医院和诊所的扩张以及政府建设医疗基础设施的支出增加,医院部门目前在市场上占据主导地位。此外,人口老龄化预计将导致慢性疼痛的患病率更高,从而推动医院对神经调节设备的需求。

区域分析:

神经调节设备市场报告的范围是主要分为北美(美国、加拿大和墨西哥)、欧洲(西班牙、英国、德国、法国、意大利和欧洲其他地区)、亚太地区(韩国、中国、印度、日本、澳大利亚和亚太其他地区)、中东和非洲(南非、沙特阿拉伯、阿联酋以及中东和非洲其他地区)以及南美洲和中美洲(巴西、阿根廷以及南美洲和中美洲其他地区) ).

就收入而言,2022年北美在神经调节设备市场份额中占据主导地位。神经系统疾病患病率不断上升、研发支出高昂、FDA批准的产品数量不断增加以及技术进步增加了该地区对神经调节设备的需求。

竞争格局和主要公司:

神经调节设备市场报告重点关注雅培(圣路易斯)等市场中的知名企业。 Jude Medical, Inc)、LivaNova PLC、Boston Scientific Corporation、Aleva Neurotherapeutics SA、Bioventus、EnteroMedics Inc、Nevro Corporation、NeuroPace Inc、Synapse Biomedical Inc 和 Neurosigma Inc. 神经调节设备市场预测可以帮助利益相关者规划其增长战略。这些公司专注于新技术、升级现有产品和拓展市场,以满足全球不断增长的消费者需求。根据公司新闻稿,以下是最近的一些关键进展:

2023 年 8 月,美敦力公司 (Medtronic plc) 的 Inceptiv 闭环可充电脊髓刺激器 (SCS) 获得了 CE 标志批准。它是第一款具有闭环功能的美敦力 SCS 设备,可感知每个人独特的生物信号,并根据需要随时调整刺激,以使治疗与日常生活运动保持一致。2023 年 8 月,雅培获得批准因其采用 FlexBurst360 疗法的新型 Proclaim Plus 脊髓刺激 (SCS) 系统而获得美国食品和药物管理局 (FDA) 的认可。 FlexBurst360 疗法是雅培专有的下一代 BurstDR 刺激疗法,可覆盖躯干和/或四肢的六个区域的疼痛。它有助于根据个人的治疗需求进行调整的编程。
  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which end user segment is dominating the neuromodulation device market?

The neuromodulation device market, based on end user, segmented into hospitals, clinics, and home healthcare. In 2022, the hospitals segment dominated the neuromodulation devices market share.

Which region is the fastest growing the neuromodulation device market?

Asia Pacific is expected to be the fastest growing region in the neuromodulation device market. The rising prevalence of neurological diseases and the development of neuromodulation devices are likely to enhance the market's growth in the coming years. China is among the most populated countries in the world, and the country has a maximum number of patients suffering from neurological disorders.

Which biomaterial segment is dominating the neuromodulation device market?

The neuromodulation device market, based on application, is segmented into metallic, polymeric, and ceramic. In 2022, the metallic segment dominated the market share. However, the polymeric segment is likely to register the highest CAGR during 2022–2030.

Which application segment is dominating the neuromodulation device market?

The neuromodulation device market, based on application, is segmented into deep brain stimulation (DBS), sacral nerve stimulation (SNS), gastric electrical stimulation (GES), spinal cord stimulation (SCS), and vagus nerve stimulation (VNS). The spinal cord stimulation segment held the largest market share in 2022 and is expected to record the highest CAGR in the market during 2022–2030.

Which product segment is dominating the neuromodulation device market?

The neuromodulation device market, based on type, is bifurcated into external and internal. The internal neuromodulation segment held a larger neuromodulation devices market share in 2022. However, the external neuromodulation segment is likely to register a higher CAGR during 2022–2030.

Which country is dominating the neuromodulation device market?

US holds the largest market share in neuromodulation device market. the incidence of neurovascular diseases is rising significantly, and it is among the leading causes of death across the country. Rising incidence of neurological diseases such as Parkinson's disease (PD), increasing awareness about neurological disorders, and growing investments in developing transcranial stimulators are among the main factors driving the overall neuromodulation devices market growth in the US.

Who are the major players in the neuromodulation device market?

The neuromodulation device market majorly consists of the players such as Abbott (St. Jude Medical, Inc.), LivaNova PLC, Boston Scientific Corporation, Aleva Neurotherapeutics SA, Bioventus, EnteroMedics Inc, Nevro Corporation, NeuroPace Inc, Synapse Biomedical Inc, Neurosigma Inc among others.

What are the driving factors for the neuromodulation device market across the globe?

The factors that are driving growth of the market are the rising cases of spinal cord injury and increasing prevalence of neurological disorders.

What is neuromodulation device?

Neuromodulation use is growing rapidly, with a wide range of implantable and noninvasive technology-based methods for the treatment of neuropsychiatric and neurological disorders. Therapies such as intracranial cortical stimulation (ICS), transcranial magnetic stimulation (TMS), deep brain stimulation (DBS), and transcranial direct current stimulation (tDCS) have shown promising results across a range of neuropsychiatric and neurological disorders. Neuromodulation devices are advanced medical instruments that can adjust the activity of the nervous system. The technology is used to treat movement disorders such as dystonia, Parkinson’s disease, and tremor; tinnitus; obsessive compulsive disorder; sensory disabilities; epilepsy; bladder control; headache; chronic pain; stroke; minimally conscious state; spasticity; and spinal cord injury.

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

The List of Companies - Neuromodulation Devices Market

  1. Abbott (St. Jude Medical, Inc.)
  2. LivaNova PLC
  3. Boston Scientific Corporation
  4. Aleva Neurotherapeutics SA
  5. Bioventus
  6. EnteroMedics Inc.
  7. Nevro Corporation
  8. NeuroPace Inc.
  9. Synapse Biomedical, Inc.
  10. Neurosigma, Inc

Buy Now  

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.